Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.
Tokushige K, Ikejima K, Ono M, Eguchi Y, Kamada Y, Itoh Y, Akuta N, Yoneda M, Iwasa M, Yoneda M, Otsuka M, Tamaki N, Kogiso T, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Tokushige K, et al. Among authors: yoneda m. J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17. J Gastroenterol. 2021. PMID: 34533632 Free PMC article. Review.
Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.
Yoneda M, Mawatari H, Fujita K, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A. Yoneda M, et al. J Gastroenterol. 2007 May;42(5):375-81. doi: 10.1007/s00535-007-2014-3. Epub 2007 May 25. J Gastroenterol. 2007. PMID: 17530362
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A. Yoneda M, et al. J Gastroenterol. 2007 Jul;42(7):573-82. doi: 10.1007/s00535-007-2060-x. Epub 2007 Jul 25. J Gastroenterol. 2007. PMID: 17653654
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A. Yoneda M, et al. Dig Liver Dis. 2008 May;40(5):371-8. doi: 10.1016/j.dld.2007.10.019. Epub 2007 Dec 20. Dig Liver Dis. 2008. PMID: 18083083
Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).
Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, Iida H, Kato S, Hosono K, Fujita K, Yoneda K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Abe Y, Kubota K, Saito S, Maeyama S, Wada K, Nakajima A. Yoneda M, et al. Among authors: yoneda k. BMC Gastroenterol. 2008 Jun 27;8:27. doi: 10.1186/1471-230X-8-27. BMC Gastroenterol. 2008. PMID: 18588668 Free PMC article.
Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).
Yoneda M, Uchiyama T, Kato S, Endo H, Fujita K, Yoneda K, Mawatari H, Iida H, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Kobayashi N, Kubota K, Saito S, Maeyama S, Sagara M, Aburatani H, Kodama T, Nakajima A. Yoneda M, et al. Among authors: yoneda k. BMC Gastroenterol. 2008 Nov 14;8:53. doi: 10.1186/1471-230X-8-53. BMC Gastroenterol. 2008. PMID: 19014569 Free PMC article.
Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease.
Akiyama T, Yoneda M, Inamori M, Iida H, Endo H, Hosono K, Yoneda K, Fujita K, Koide T, Tokoro C, Takahashi H, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A. Akiyama T, et al. Among authors: yoneda k, yoneda m. BMC Gastroenterol. 2009 Jul 21;9:56. doi: 10.1186/1471-230X-9-56. BMC Gastroenterol. 2009. PMID: 19622165 Free PMC article.
The continuous real-time 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the BreathID system.
Mawatari H, Inamori M, Fujita K, Yoneda M, Iida H, Endo H, Hosono K, Nozaki Y, Yoneda K, Akiyama T, Takahashi H, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A. Mawatari H, et al. Among authors: yoneda k, yoneda m. Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1436-8. Hepatogastroenterology. 2009. PMID: 19950806
A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
Sumida Y, Yoneda M, Hyogo H, Yamaguchi K, Ono M, Fujii H, Eguchi Y, Suzuki Y, Imai S, Kanemasa K, Fujita K, Chayama K, Yasui K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Sumida Y, et al. Among authors: yoneda m. J Gastroenterol. 2011 Feb;46(2):257-68. doi: 10.1007/s00535-010-0305-6. Epub 2010 Sep 15. J Gastroenterol. 2011. PMID: 20842510
1,714 results